expert comments on the risks and benefits of tirzepatide following the death of Susan McGowan
Scientists comment on the risks and benefits of tirzepatide (Mounjaro) after a UK death linked to the drug. Prof … read more
Scientists comment on the risks and benefits of tirzepatide (Mounjaro) after a UK death linked to the drug. Prof … read more
A study published in Addiction looks at the use of GLP-1 receptor agonists (Ozempic) for opioid and alcohol addiction. Prof Matt … read more
Scientists comment on NHS England proposing a phased launch of the weight loss drug Mounjaro to NICE. Dr Simon … read more
A conference abstract presented at the European Association for the Study of Diabetes looks at a study of a once-a-day … read more
A study published in JAMA Network Open looks at semaglutide use and suicidality. Dr Riccardo De Giorgi, Clinical Lecturer in the … read more
Findings published in The Lancet Diabetes & Endocrinology looks at the NHS soups and shakes diet for diabetes remission. Dr … read more
A conference abstract at the Alzheimer’s Association International Conference looks at weight loss drug liraglutide and Alzheimer’s disease. Dr … read more
A study published in Annals of Internal Medicine looks at semaglutide and tobacco use in people with type 2 diabetes. Rachel … read more
Scientists react to MHRA approving semaglutide for heart problems. Prof John Wilding, Professor of Medicine, Department of Cardiovascular and … read more
A study published in JAMA Ophthalmology looks at optic neuropathy as a possible side effect of semaglutide. Prof Graham McGeown, … read more
Scientists react to NICE publishing draft guidance on tirzepatide for obesity. Dr Simon Cork, Senior Lecturer in Physiology, Anglia … read more
A study published in Nature Medicine and an accompanying conference abstract and poster looks at long term weight loss effects of semaglutide … read more
Scientists react to questions raised about obesity drugs and fertility. Prof Ying Cheong, Professor of Reproductive Medicine and Honorary … read more
A study published in Annals of Internal Medicine looks at the effect of time-restricted eating on body weight. Dr Jacopo Scotucci, … read more
A study published in the Lancet looks at semaglutide and obesity-related heart failure. Prof Kazem Rahimi, Professor of Cardiovascular Medicine … read more
A study published in the New England Journal of Medicine looks at semaglutide and heart failure in patients with … read more
Scientists react to obesity conference abstracts about sweeteners and weight loss control. Prof Kevin McConway, Emeritus Professor of Applied … read more
A study published in JAMA looks at the risk of gastrointestinal adverse effects when taking semaglutide or liraglutide weight loss … read more
A conference abstract (not a published paper) presented at the European Congress on Obesity (ECO) looks at cardiovascular risk in patients … read more